Physician profile
Kelsey Gray
NPI 1952899940
$494.03
in general payments reported to CMS, 2019-2025
11 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.22 · 2024: $136 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $123.06 | 2024-2025 | |
| Medtronic, INC. | $81.47 | 2024 | Corevalve Evolut R |
| Heartflow, INC. | $67.48 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.52 | 2023-2025 | Lifevest |
| Amgen INC. | $48.82 | 2024-2025 | Repatha, Repatha |
| Pfizer INC. | $25.64 | 2025 | |
| Novo Nordisk INC | $23.10 | 2025 | Wegovy |
| Biobeat USA INC. | $18.45 | 2024 | Bb-613 Bpm Kit |
| Inspire Medical Systems, INC. | $17.59 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.27 | 2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $13.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.